Christopher Roberts

6PUBLICATIONS
40CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Gene expression (incl. microarray and other genome-wide approaches)Nanotoxicology, health and safetyNutritional epidemiologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Dec 13, 2025
HLA-DQA1*05:01 and DQA1*05:05 inform choice of anti-tumor necrosis factor and concomitant use of immunomodulators in patients with inflammatory bowel disease.

Qian Zhang, Mohammed Sharip, Christopher Roberts

|Jul 25, 2025
Editorial: LAMP Lights the Way-A Pragmatic Case for NUDT15 Screening Across Diverse Populations-Authors' Reply.

Chris Roberts, James R Goodhand, Tariq Ahmad

|Jun 23, 2025
Clinical Utility and Cost-Effectiveness of Pretreatment NUDT15 Pharmacogenetic Testing to Prevent Thiopurine-Induced Myelosuppression: A Genotype-First Reverse Phenotyping Cohort Study Within the UK NIHR Inflammatory Bowel Disease Bioresource.

Christopher Roberts, Jaime Peters, Aleksejs Sazonvos

|Jun 22, 2023
Prevalence of NUDT15 Genetic Variants and Incidence of Thiopurine-induced Leukopenia in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.

Natalie Yu, Danujan Sriranganathan, Gareth J Walker

|Jun 02, 2023
Pretreatment Vitamin D Concentrations Do Not Predict Therapeutic Outcome to Anti-TNF Therapies in Biologic-Naïve Patients With Active Luminal Crohn's Disease.

Neil Chanchlani, Simeng Lin, Rebecca Smith

|Dec 27, 2022
Factors influencing rectal hypersensitivity in irritable bowel syndrome: A systematic review and meta-analysis.

Christopher Roberts, Ahmed Albusoda, Adam D Farmer

Pageof 1

Frequent Collaborators

6 joint publications

Tariq Ahmad

4 joint publications

James R Goodhand

2 joint publications

Miles Parkes

2 joint publications

Neil Chanchlani